Illumina
在场
是其中之一......
Illumina 是一家在股票代码 ILMN (US) 下上市的公司。
Illumina 拥有 3家子公司，其中包括 Grail、Illumina Ventures 和 Pacific Biosciences。
他们在：
高管
查看带有其 85 名主要高管的组织结构图
Illumina 搜索最多的简介
- Jacob Thaysen, Chief Executive Officer and Director
- Frances Arnold, Director
- Phil Schiller, Director
高管在Illumina变化
- Joydeep Goswami, Chief Financial Officer, Chief Strategy and Corporate Development Officer, 将于 20246月30 退休 (新闻发布的2024四月12号).
- Ankur Dhingra已作为Chief Financial Officer加入公司 (新闻发布的2024四月12号).
- Bas Verhoef 曾任 Head of Region Europe, 现升职为 Interim Chief Commercial Officer (新闻发布的2024一月7号).
创建提醒
跟踪 Illumina 的高管变动
医疗设备
Illumina 拥有 986 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。
Popular M&A news in 医疗设备
- Medigus将在Apr 12, 2024将其名称改为Xylo Technologies。 (公布2024四月12号).
- Johnson & Johnson has announced the acquisition of Shockwave Medical (公布2024四月6号).
- Carlsmed 刚刚宣布为 52 筹款数百万美元。 (公布2024三月22号).
医疗设备 行业的其他推荐联系人
消息
Illumina 的最新新闻稿
- Illumina's planned divestment of GRAIL approved by the European Commission
- Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer
- Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024
- Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2023
- Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023
- The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk
- Illumina to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 8, 2024
- Illumina expands collaboration with Janssen to advance molecular residual disease cancer test
- Press Release 2024
- Illumina submits Form 10 to the Securities and Exchange Commission
- View more press releases Close
关于 Illumina 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Jacob Thaysen 
